Bruker Stock Today
BRKR Stock | USD 93.98 0.12 0.13% |
Performance16 of 100
| Odds Of DistressLess than 1
|
Bruker is selling at 93.98 as of the 28th of March 2024; that is 0.13% increase since the beginning of the trading day. The stock's lowest day price was 93.98. Bruker has a very small chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Equity ratings for Bruker are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of June 2022 and ending today, the 28th of March 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 4th of August 2000 | Category Healthcare | Classification Health Care |
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts. The company has 137.67 M outstanding shares of which 3.62 M shares are currently shorted by private and institutional investors with about 4.18 trading days to cover. More on Bruker
Moving together with Bruker Stock
0.75 | MDGL | Madrigal Pharmaceuticals Financial Report 14th of May 2024 | PairCorr |
0.89 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
0.86 | MDWD | Mediwound Financial Report 4th of June 2024 | PairCorr |
Moving against Bruker Stock
0.89 | KA | Kineta Inc Report 29th of March 2024 | PairCorr |
0.79 | MCRB | Seres Therapeutics Financial Report 14th of May 2024 | PairCorr |
0.76 | MEIP | MEI Pharma Financial Report 9th of May 2024 | PairCorr |
0.72 | MBIO | Mustang Bio Report 3rd of April 2024 | PairCorr |
0.71 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
0.41 | MGTX | MeiraGTx Holdings PLC Financial Report 9th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 2nd of May 2024
Bruker Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bruker's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bruker or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
President and CEO, BEST | Burkhard Prause | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, ARCA Biotechnology, NASDAQ Composite, SP Midcap 400, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Life Sciences Tools & Services, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Analyst Recommendation Analysts covering Bruker report their recommendations after researching Bruker's financial statements, talking to executives and customers, or listening in on Bruker's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Bruker. The Bruker consensus assessment is calculated by taking the average forecast from all of the analysts covering Bruker. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength Based on the analysis of Bruker's profitability, liquidity, and operating efficiency, Bruker is performing exceptionally good at this time. It has a great probability to report excellent financial results in April. Financial strength of Bruker is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bruker's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Bruker's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Bruker's financial leverage. It provides some insight into what part of Bruker's total assets is financed by creditors.
|
Bruker (BRKR) is traded on NASDAQ Exchange in USA. It is located in 40 Manning Road, Billerica, MA, United States, 01821 and employs 9,707 people. Bruker is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 12.72 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bruker's market, we take the total number of its shares issued and multiply it by Bruker's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bruker conducts business under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 137.67 M outstanding shares of which 3.62 M shares are currently shorted by private and institutional investors with about 4.18 trading days to cover.
Bruker currently holds about 733.6 M in cash with 350.1 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.95.
Check Bruker Probability Of Bankruptcy
Ownership AllocationBruker retains a total of 137.67 Million outstanding shares. The majority of Bruker outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Bruker to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Bruker. Please pay attention to any change in the institutional holdings of Bruker as this could imply that something significant has changed or is about to change at the company. Also note that nearly twenty-two million twenty-seven thousand three hundred sixty-one invesors are currently shorting Bruker expressing very little confidence in its future performance.
Check Bruker Ownership Details
Bruker Stock Price Odds Analysis
In regard to a normal probability distribution, the odds of Bruker jumping above the current price in 90 days from now is about 5.54%. The Bruker probability density function shows the probability of Bruker stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Bruker has a beta of 0.8145 suggesting as returns on the market go up, Bruker average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Bruker will be expected to be much smaller as well. Additionally, bruker has an alpha of 0.269, implying that it can generate a 0.27 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Bruker to move above the current price in 90 days from now is about 5.54 (This Bruker probability density function shows the probability of Bruker Stock to fall within a particular range of prices over 90 days) .
Bruker Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Bruker that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bruker's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bruker's value.Instituion | Recorded On | Shares | |
Fuller & Thaler Asset Management Inc | 2023-12-31 | 1.9 M | |
Td Asset Management Inc | 2023-12-31 | 1.7 M | |
Geode Capital Management, Llc | 2023-12-31 | 1.6 M | |
Brown Advisory Holdings Inc | 2023-12-31 | 1.6 M | |
Millennium Management Llc | 2023-12-31 | 1.4 M | |
T. Rowe Price Associates, Inc. | 2023-12-31 | 1.4 M | |
Congress Asset Management Company, Llp | 2023-12-31 | 1.4 M | |
Dimensional Fund Advisors, Inc. | 2023-12-31 | 1.2 M | |
Norges Bank | 2023-12-31 | 1 M | |
T. Rowe Price Investment Management,inc. | 2023-12-31 | 13.2 M | |
Vanguard Group Inc | 2023-12-31 | 9.9 M |
Bruker Historical Income Statement
Bruker Income Statement is one of the three primary financial statements used for reporting Bruker's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Bruker revenue and expense. Bruker Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Bruker's Total Other Income Expense Net is relatively stable compared to the past year. As of 03/28/2024, Depreciation And Amortization is likely to grow to about 120.6 M, while Cost Of Revenue is likely to drop slightly above 737 M. View More FundamentalsBruker Stock Against Markets
Picking the right benchmark for Bruker stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bruker stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bruker is critical whether you are bullish or bearish towards Bruker at a given time. Please also check how Bruker's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bruker without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
All Next | Launch Module |
Bruker Corporate Directors
Bruker corporate directors refer to members of a Bruker board of directors. The board of directors generally takes responsibility for the Bruker's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Bruker's board members must vote for the resolution. The Bruker board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.Gilles Martin | Independent Director | Profile | |
Marc Kastner | Independent Director | Profile | |
Hermann Requardt | Director | Profile | |
WolfDieter Emmerich | Independent Director | Profile |
How to buy Bruker Stock?
Before investing in Bruker, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Bruker. To buy Bruker stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Bruker. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Bruker stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Bruker stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Bruker stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Bruker, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Bruker Stock please use our How to Invest in Bruker guide.
Already Invested in Bruker?
The danger of trading Bruker is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bruker is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bruker. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bruker is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Bruker is a strong investment it is important to analyze Bruker's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bruker's future performance. For an informed investment choice regarding Bruker Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Bruker Stock analysis
When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stocks Directory Find actively traded stocks across global markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is Bruker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bruker. If investors know Bruker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bruker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.127 | Dividend Share 0.2 | Earnings Share 2.9 | Revenue Per Share 20.249 | Quarterly Revenue Growth 0.206 |
The market value of Bruker is measured differently than its book value, which is the value of Bruker that is recorded on the company's balance sheet. Investors also form their own opinion of Bruker's value that differs from its market value or its book value, called intrinsic value, which is Bruker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bruker's market value can be influenced by many factors that don't directly affect Bruker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bruker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bruker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bruker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.